UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFN
1726
DELISTED
Infinera Corporation Common Stock
INFN
| $1.55M | ﹤0.01% |
200,104
-6,897
| -3% | -$50.1K |
|
1727
Tidewater
TDW
$4.46B
| $1.55M | ﹤0.01% |
35,177
+1,112
| +3% | +$47.8K |
|
|
MODN
1728
DELISTED
MODEL N, INC.
MODN
| $1.55M | ﹤0.01% |
46,322
+3,081
| +7% | +$112K |
|
|
BWIN
1729
Baldwin Insurance Group
BWIN
$2.79B
| $1.55M | ﹤0.01% |
60,850
+1,831
| +3% | +$50.9K |
|
1730
Energy Recovery
ERII
$408M
| $1.55M | ﹤0.01% |
67,133
+5,369
| +9% | +$118K |
|
1731
A10 Networks
ATEN
$2.06B
| $1.55M | ﹤0.01% |
+99,855
| New | +$1.52M |
|
|
EHAB
1732
DELISTED
Enhabit
EHAB
| $1.54M | ﹤0.01% |
110,974
+14,636
| +15% | +$210K |
|
|
CFLT
1733
DELISTED
Confluent
CFLT
| $1.54M | ﹤0.01% |
64,116
| – | – |
|
1734
DNOW Inc
DNOW
$3.01B
| $1.54M | ﹤0.01% |
138,334
+1,076
| +0.8% | +$13.5K |
|
1735
Axsome Therapeutics
AXSM
$11.4B
| $1.53M | ﹤0.01% |
24,835
-2,119
| -8% | -$139K |
|
1736
Sphere Entertainment
SPHR
$5.84B
| $1.53M | ﹤0.01% |
25,918
+1,724
| +7% | +$93.2K |
|
|
EVA
1737
DELISTED
Enviva Inc.
EVA
| $1.53M | ﹤0.01% |
52,979
+3,105
| +6% | +$127K |
|
1738
MillerKnoll
MLKN
$1.64B
| $1.53M | ﹤0.01% |
74,727
+6,729
| +10% | +$151K |
|
1739
Alpha Metallurgical Resources
AMR
$1.95B
| $1.52M | ﹤0.01% |
+9,726
| New | +$1.56M |
|
|
NVEE
1740
DELISTED
NV5 Global
NVEE
| $1.52M | ﹤0.01% |
58,300
+3,908
| +7% | +$117K |
|
1741
Liberty Latin America Class C
LILAK
$1.65B
| $1.52M | ﹤0.01% |
201,765
+1,064
| +0.5% | +$8.47K |
|
1742
Perdoceo Education
PRDO
$1.97B
| $1.51M | ﹤0.01% |
112,664
+11,494
| +11% | +$161K |
|
|
INVX
1743
Innovex International
INVX
$2.04B
| $1.51M | ﹤0.01% |
52,624
-1,155
| -2% | -$34.2K |
|
1744
Apogee Enterprises
APOG
$887M
| $1.51M | ﹤0.01% |
+34,857
| New | +$1.57M |
|
1745
Establishment Labs
ESTA
$2.21B
| $1.51M | ﹤0.01% |
22,244
-1,541
| -6% | -$106K |
|
|
PMT
1746
PennyMac Mortgage Investment
PMT
$818M
| $1.51M | ﹤0.01% |
122,125
+3,844
| +3% | +$51.7K |
|
|
HEES
1747
DELISTED
H&E Equipment Services
HEES
| $1.5M | ﹤0.01% |
34,007
-2,890
| -8% | -$141K |
|
|
EVBG
1748
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $1.5M | ﹤0.01% |
43,320
+7,249
| +20% | +$232K |
|
1749
Viper Energy
VNOM
$15.3B
| $1.5M | ﹤0.01% |
53,600
+700
| +1% | +$21K |
|
|
SPWR
1750
DELISTED
SunPower Corporation Common Stock
SPWR
| $1.5M | ﹤0.01% |
108,270
+6,827
| +7% | +$107K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.